These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16321039)

  • 1. Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.
    Hoare M; Levy MS; Bracewell DG; Doig SD; Kong S; Titchener-Hooker N; Ward JM; Dunnill P
    Biotechnol Prog; 2005; 21(6):1577-92. PubMed ID: 16321039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
    Kreijtz JH; Osterhaus AD; Rimmelzwaan GF
    Hum Vaccin; 2009 Mar; 5(3):126-35. PubMed ID: 18948744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
    Wood JM; Robertson JS
    Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for developing vaccines against H5N1 influenza A viruses.
    Horimoto T; Kawaoka Y
    Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of influenza vaccine strains and developing pandemic vaccines.
    Wood JM
    Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccines: a main problem in control of pandemics.
    Ghendon Y
    Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threat and prospects for control of an influenza pandemic.
    Stiver HG
    Expert Rev Vaccines; 2004 Feb; 3(1):35-42. PubMed ID: 14761242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for pandemic influenza.
    Luke CJ; Subbarao K
    Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine supply: building long-term sustainability.
    Hehme N; Colegate T; Palache B; Hessel L
    Vaccine; 2008 Sep; 26 Suppl 4():D23-6. PubMed ID: 19230154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.
    Williams JA; Luke J; Langtry S; Anderson S; Hodgson CP; Carnes AE
    Biotechnol Bioeng; 2009 Aug; 103(6):1129-43. PubMed ID: 19408315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology transfer hub for pandemic influenza vaccine.
    Friede M; Serdobova I; Palkonyay L; Kieny MP
    Vaccine; 2009 Jan; 27(5):631-2. PubMed ID: 19022316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of influenza deoxyribonucleic acid-based vaccine using agmatine monolith.
    Bicho D; Caramelo-Nunes C; Sousa A; Sousa F; Queiroz JA; Tomaz CT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():153-61. PubMed ID: 26827278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The WHO's petition of a vaccine against the pandemic].
    Nau JY
    Rev Med Suisse; 2006 Nov; 2(86):2579. PubMed ID: 17168051
    [No Abstract]   [Full Text] [Related]  

  • 18. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.
    Straetemans M; Buchholz U; Reiter S; Haas W; Krause G
    BMC Public Health; 2007 Sep; 7():236. PubMed ID: 17825095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global production capacity of seasonal influenza vaccine in 2011.
    Partridge J; Kieny MP
    Vaccine; 2013 Jan; 31(5):728-31. PubMed ID: 23149268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD
    Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.